Inhaled antibody therapy shows promise for COVID-19 treatment
Source: News-Medical.Net
The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high antibody levels in the airway—offering a faster and more effective way to fight COVID-19.
Study: A randomized, double-blind, Phase 1, single- an… [4843 chars]